ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer’s disease (AD) and other neurodegenerative disorders, today announce ...
"You’ll get the inside scoop DIRECT from me, President Trump," the email promised to supporters who quickly paid to become a "National Security Briefing Member" The White House via X Account/Anadolu ...
Leaked API keys are nothing new, but the scale of the problem in front-end code has been largely a mystery - until now. Intruder’s research team built a new secrets detection method and scanned 5 ...
The “Today” show anchor, in a message on social media with her siblings, said the return of their mother Nancy “is the only way we will have peace.” By Reis Thebault Reporting from Tucson, Ariz. In a ...
Cambridge, Massachusetts, Feb. 04, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer’s ...
Cambridge, Massachusetts, Feb. 04, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer's ...
(RTTNews) - ProMIS Neurosciences Inc. (PMN), a clinical-stage biotechnology company, has announced on Friday a private investment in public equity financing of up to approximately $175 million. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results